# SLC38A1

## Overview
SLC38A1 is a gene that encodes the protein solute carrier family 38 member 1 (SNAT1), which is a sodium-coupled neutral amino acid transporter. SNAT1 is a transmembrane protein characterized by its involvement in the transport of neutral amino acids, such as glutamine, alanine, and serine, across cell membranes. This protein plays a critical role in cellular metabolism by facilitating the uptake of amino acids necessary for protein synthesis, energy production, and other metabolic processes. SNAT1 is predominantly expressed in glutamatergic neurons and is implicated in maintaining cellular homeostasis and supporting brain development. The gene's expression and the protein's function are significant in various physiological and pathological contexts, including cancer progression and immune response regulation (Xie2014Overexpression; Mackenzie2003Functional; Sapkota2024Investigation).

## Structure
The SLC38A1 gene encodes the SNAT1 protein, a member of the solute carrier family 38, which is involved in the transport of neutral amino acids. The SNAT1 protein is predicted to have 11 hydrophobic transmembrane domains (TMDs) based on hydropathy analysis. The absence of an N-terminal signal sequence suggests that the N-terminus is cytoplasmic, while the C-terminus is extracellular, supported by biochemical analysis of the related SNAT2 protein (Mackenzie2004Sodiumcoupled). The protein features a large glycosylated loop between TMD V and VI, which is extracellular, and consensus glycosylation sites are present in predicted extracellular hydrophilic loops, indicating potential post-translational modifications (Mackenzie2004Sodiumcoupled).

SNAT1 is characterized by a 5+5 inverted repeat fold, a common structural motif in the SLC38 family (Pochini2014Membrane). The protein operates as a Na+-dependent transporter, facilitating the uptake of small, neutral aliphatic amino acids, with a preference for L-alanine (Mackenzie2003Functional). While specific details on the tertiary and quaternary structures are not provided, the protein's functional properties suggest a complex structure that supports its role in amino acid transport.

## Function
SLC38A1, also known as SNAT1, is a sodium-coupled neutral amino acid transporter that plays a crucial role in the uptake of amino acids such as glutamine, alanine, and serine into cells. This transporter is primarily active in the plasma membrane, where it facilitates the net accumulation of cellular glutamine, an essential amino acid for various cellular functions, including the synthesis of non-essential amino acids, proteins, nucleotides, and the antioxidant glutathione. It also provides intermediates for the tricarboxylic acid cycle, supporting cellular metabolism and energy production (Sapkota2024Investigation).

SLC38A1 is part of the SLC38 family, which includes 11 members involved in the transport of glutamine and other neutral amino acids across cell and organelle membranes. It is particularly effective in glutamine accumulation due to its unidirectional transport and high affinity for glutamine, making it suitable for cells with high glutamine requirements (Sapkota2024Investigation). In healthy human cells, SLC38A1 is strongly expressed in glutamatergic neurons, where it is involved in maintaining the intestinal barrier structure and immune function (Xie2014Overexpression). It also plays a role in brain development and may influence protein anabolism by regulating mTOR activity (Sapkota2024Investigation).

## Clinical Significance
Alterations in the expression of the SLC38A1 gene, which encodes the SNAT1 transporter, have significant implications in various diseases, particularly cancer and inflammatory conditions. In cancer, SNAT1 is crucial for maintaining glutaminolysis, a metabolic pathway essential for tumor growth. Its expression is notably higher in clear cell renal cell carcinoma (CCRCC) compared to normal tissues, driven by factors such as HIF1α and the hepatic growth factor oncogenic pathway. This makes SNAT1 a potential target for cancer treatment, as its activity is vital for the proliferation of many fast-growing cancer cells (Bröer2016Deletion).

In the context of immune response, SLC38A1 plays a critical role in Th1 cell proliferation during inflammation. Its deficiency leads to reduced intracellular glutamine levels, affecting metabolic pathways and impairing Th1 cell expansion and function. This suggests that SLC38A1 is essential for Th1 cell activities in autoimmune diseases like Experimental Autoimmune Encephalomyelitis (EAE) and inflammatory bowel disease (IBD), although it is not crucial for Th1 effector functions such as IFNγ production (Sugiura2023TissueSpecific). These findings highlight the potential of targeting SLC38A1 in therapeutic interventions for cancer and autoimmune diseases.

## Interactions
SLC38A1, a member of the solute carrier family, is involved in various protein interactions that influence its function in cellular processes. In hepatocellular carcinoma (HCC), SLC38A1 interacts with OTUD5, a deubiquitinating enzyme. OTUD5 binds to SLC38A1 and regulates its stability by deubiquitination, preventing its degradation. This interaction is crucial for the proliferation of HCC cells, as OTUD5 overexpression stabilizes SLC38A1, while its knockdown leads to increased ubiquitination and degradation of SLC38A1 (Yang2024OTUD5).

In melanoma, SLC38A1 is part of a regulatory pathway involving circTADA2A and CNBP. CircTADA2A acts as a tumor suppressor by interacting with CNBP, which in turn affects the transcription of SLC38A1. Overexpression of circTADA2A leads to decreased SLC38A1 expression by inhibiting CNBP's ability to activate the SLC38A1 promoter. This interaction is significant in reducing melanoma cell proliferation and migration (Zhang2024circTADA2A).

These interactions highlight the role of SLC38A1 in cancer progression and suggest potential therapeutic targets for modulating its activity in different cancer types.


## References


[1. (Xie2014Overexpression) Jing Xie, Ping Li, Hui-feng Gao, Jian-xin Qian, Ling-Yan Yuan, and Jie-jun Wang. Overexpression of slc38a1 is associated with poorer prognosis in chinese patients with gastric cancer. BMC Gastroenterology, April 2014. URL: http://dx.doi.org/10.1186/1471-230X-14-70, doi:10.1186/1471-230x-14-70. This article has 43 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1471-230X-14-70)

2. (Sugiura2023TissueSpecific) Tissue-Specific Dependence of Th1 Cells on the Amino Acid Transporter SLC38A1 in Inflammation. This article has 1 citations.

[3. (Pochini2014Membrane) Lorena Pochini, Mariafrancesca Scalise, Michele Galluccio, and Cesare Indiveri. Membrane transporters for the special amino acid glutamine: structure/function relationships and relevance to human health. Frontiers in Chemistry, August 2014. URL: http://dx.doi.org/10.3389/fchem.2014.00061, doi:10.3389/fchem.2014.00061. This article has 178 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fchem.2014.00061)

[4. (Mackenzie2004Sodiumcoupled) Bryan Mackenzie and Jeffrey D. Erickson. Sodium-coupled neutral amino acid (system n/a) transporters of the slc38 gene family. Pfl�gers Archiv European Journal of Physiology, 447(5):784–795, February 2004. URL: http://dx.doi.org/10.1007/s00424-003-1117-9, doi:10.1007/s00424-003-1117-9. This article has 410 citations.](https://doi.org/10.1007/s00424-003-1117-9)

[5. (Sapkota2024Investigation) Dipak Sapkota, Daxin Wang, Olaf Schreurs, Evan M. Vallenari, Sushma Pandey Dhakal, Thomas Küntziger, Burcu Sengüven Toközlü, Tor Paaske Utheim, and Farrukh Abbas Chaudhry. Investigation of roles of slc38a1 in proliferation and differentiation of mouse tongue epithelium and expression in human oral tongue squamous cell carcinoma. Cancers, 16(2):405, January 2024. URL: http://dx.doi.org/10.3390/cancers16020405, doi:10.3390/cancers16020405. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cancers16020405)

[6. (Zhang2024circTADA2A) Longjun Zhang, Le Zhang, Chi Zhang, Sunan Shi, Zhilei Cao, Changliang Shao, Jie Li, Yingshun Yang, Xi Zhang, Jian Wang, and Xiangyun Li. Circtada2a inhibited slc38a1 expression and suppresses melanoma progression through the prevention of cnbp trans-activation. PLOS ONE, 19(4):e0301356, April 2024. URL: http://dx.doi.org/10.1371/journal.pone.0301356, doi:10.1371/journal.pone.0301356. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0301356)

[7. (Bröer2016Deletion) Angelika Bröer, Farid Rahimi, and Stefan Bröer. Deletion of amino acid transporter asct2 (slc1a5) reveals an essential role for transporters snat1 (slc38a1) and snat2 (slc38a2) to sustain glutaminolysis in cancer cells. Journal of Biological Chemistry, 291(25):13194–13205, June 2016. URL: http://dx.doi.org/10.1074/jbc.m115.700534, doi:10.1074/jbc.m115.700534. This article has 191 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m115.700534)

[8. (Yang2024OTUD5) Yingnan Yang, Siying Jia, Ning Zhu, Xuelian Xiao, Ying Ma, Kangsheng Tu, Yong Guo, and Qiuran Xu. Otud5 promotes the growth of hepatocellular carcinoma by deubiquitinating and stabilizing slc38a1. Biology Direct, April 2024. URL: http://dx.doi.org/10.1186/s13062-024-00475-0, doi:10.1186/s13062-024-00475-0. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s13062-024-00475-0)

[9. (Mackenzie2003Functional) Bryan Mackenzie, Martin K.-H. Schäfer, Jeffrey D. Erickson, Matthias A. Hediger, Eberhard Weihe, and Hélène Varoqui. Functional properties and cellular distribution of the system a glutamine transporter snat1 support specialized roles in central neurons. Journal of Biological Chemistry, 278(26):23720–23730, June 2003. URL: http://dx.doi.org/10.1074/jbc.M212718200, doi:10.1074/jbc.m212718200. This article has 161 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.M212718200)